| Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome (NCT06096597) | David Sheyn | 2024-07-24 |
| Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection (NCT06454578) | Qilu Hospital of Shandong University | 2024-07-24 |
| Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone (NCT06526338) | Robert C. Martin | 2024-07-24 |
| Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis (NCT06565273) | SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd | 2024-07-24 |
| A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy (NCT06476899) | Fei Li | 2024-07-24 |
| Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer (NCT06562920) | Zhejiang Cancer Hospital | 2024-07-24 |
| Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer (NCT05896839) | National Cancer Institute (NCI) | 2024-07-24 |
| Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer (NCT06787911) | Yu Wang | 2024-07-24 |
| JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation (NCT06386146) | Jacobio Pharmaceuticals Co., Ltd. | 2024-07-24 |
| Safety and Efficacy Reconyl for Cough With/Without Sore Throat (NCT06510257) | Dexa Medica Group | 2024-07-23 |
| Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer (NCT06260033) | City of Hope Medical Center | 2024-07-23 |
| A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer (NCT06532032) | Janssen Research & Development, LLC | 2024-07-23 |
| Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma (NCT06169215) | National Cancer Institute (NCI) | 2024-07-23 |
| Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma (NCT06524466) | Sun Yat-sen University | 2024-07-23 |
| Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors (NCT06113016) | Jonsson Comprehensive Cancer Center | 2024-07-23 |
| Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture (NCT07640425) | CONNEXT | 2024-07-23 |
| Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC (NCT06578559) | Gruppo Oncologico del Nord-Ovest | 2024-07-23 |
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) (NCT06355531) | Ferrer Internacional S.A. | 2024-07-23 |
| Adebrelimab and Chemoradiotherapy in High-risk LANPC (NCT06349889) | Sun Yat-sen University | 2024-07-23 |
| Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI (NCT06333314) | UNICANCER | 2024-07-23 |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases (NCT06013423) | Fred Hutchinson Cancer Center | 2024-07-23 |
| Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) (NCT06054113) | Amgen | 2024-07-23 |
| A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) (NCT06362252) | Daiichi Sankyo | 2024-07-22 |
| A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease (NCT06544616) | Janssen Pharmaceutica N.V., Belgium | 2024-07-22 |
| A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy (NCT06384261) | OncoVerity, Inc. | 2024-07-22 |
| Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy (NCT05891795) | Stanford University | 2024-07-22 |
| Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer (NCT06793137) | AC Camargo Cancer Center | 2024-07-22 |
| To Compare Post-op Analgesic Effectiveness of Ropivicaine+Dexamethasone and Ropivacane+Dexmetomidine in TAP Block in Stoma Reversal Under GA in Terms of Duration of Analgesia. (NCT07368075) | Sahiwal medical college sahiwal | 2024-07-22 |
| Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma (NCT06484153) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-07-22 |
| Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens (NCT06492889) | Gynuity Health Projects | 2024-07-22 |
| N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma (NCT06528496) | Memorial Sloan Kettering Cancer Center | 2024-07-22 |
| A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer (NCT06431490) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-07-22 |
| To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA (NCT06436911) | Entos Pharmaceuticals Inc. | 2024-07-22 |
| Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer (NCT06179303) | University of Washington | 2024-07-22 |
| PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer (NCT06172127) | MedSIR | 2024-07-22 |
| A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients (NCT06329141) | Glaceum | 2024-07-22 |
| INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM" (NCT06886399) | Industrial Microbiology LLP | 2024-07-22 |
| the Effects of Fish Oil Supplements on Choroidal Thickness and Blood Flow Perfusion in Children and Adolescents (NCT06877494) | Shanghai Eye Disease Prevention and Treatment Center | 2024-07-21 |
| Resveratol in Diabetic Nephropathy (NCT07332819) | Ain Shams University | 2024-07-21 |
| A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma (NCT06472895) | Peking University Cancer Hospital & Institute | 2024-07-20 |
| Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC (NCT06472713) | Ming-Yuan Chen | 2024-07-20 |
| Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS (NCT06505941) | Southeast University, China | 2024-07-20 |
| Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab (NCT06498622) | Anhui Provincial Hospital | 2024-07-20 |
| HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma (NCT06475287) | Fudan University | 2024-07-20 |
| GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma (NCT06490341) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-07-20 |
| Plasmodium Immunotherapy for Advanced Ovarian Cancer (NCT05924776) | CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. | 2024-07-20 |
| Prospective Phase II Study on Continuous Circumferential Reinforcement of Laparoscopic Rectal Anastomosis to Prevent Complications (NCT06495853) | ZHI-ZHONG PAN | 2024-07-20 |
| A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients (NCT06441812) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-07-19 |
| Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers (NCT06425133) | Centre Hospitalier Universitaire de Besancon | 2024-07-19 |
| A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD (NCT06405633) | Wave Life Sciences USA, Inc. | 2024-07-19 |
| Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC (NCT06542588) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-07-19 |
| Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition (NCT06564753) | Biomed Industries, Inc. | 2024-07-19 |
| IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients (NCT06765005) | Shanghai Mabgeek Biotech.Co.Ltd | 2024-07-19 |
| Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. (NCT06590857) | RayzeBio, Inc. | 2024-07-19 |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (NCT06226883) | Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | 2024-07-18 |
| Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study (NCT06547203) | Sun Yat-sen University | 2024-07-18 |
| VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS (NCT06536959) | Beijing 302 Hospital | 2024-07-18 |
| Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma (NCT06504199) | Institute of Hematology & Blood Diseases Hospital, China | 2024-07-18 |
| A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality (NCT06547125) | AbbVie | 2024-07-18 |
| Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation (NCT06252870) | Nantes University Hospital | 2024-07-18 |
| TP03HN106 in Patients With Critical Limb Ischemia (NCT06482892) | Talengen Institute of Life Sciences, Shenzhen, P.R. China. | 2024-07-18 |
| Prevent Cardiac Surgery Associated AKI Trial (NCT06620523) | George Washington University | 2024-07-18 |
| PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma (NCT05096481) | Nationwide Children's Hospital | 2024-07-18 |
| Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome (NCT06527937) | Aquestive Therapeutics | 2024-07-17 |
| Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations (NCT06517953) | Sun Yat-sen University | 2024-07-17 |
| A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) (NCT06413654) | Shanghai Jiaolian Drug Research and Development Co., Ltd | 2024-07-17 |
| A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease (NCT06531395) | Kiniksa Pharmaceuticals International, plc | 2024-07-17 |
| A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04) (NCT06483334) | Merck Sharp & Dohme LLC | 2024-07-17 |
| Letrozole in Uterine Leiomyosarcoma (NCT05649956) | GOG Foundation | 2024-07-17 |
| Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma (NCT06207799) | M.D. Anderson Cancer Center | 2024-07-17 |
| A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH） (NCT06561841) | Haisco Pharmaceutical Group Co., Ltd. | 2024-07-17 |
| A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. (NCT06434597) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-07-17 |
| A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease (NCT06481306) | Bristol-Myers Squibb | 2024-07-17 |
| A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps (NCT06454240) | Sanofi | 2024-07-17 |
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer (NCT05705492) | OHSU Knight Cancer Institute | 2024-07-17 |
| A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease (NCT06442137) | Shanghai Municipal Hospital of Traditional Chinese Medicine | 2024-07-17 |
| Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer (NCT06437574) | Cedars-Sinai Medical Center | 2024-07-16 |
| Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer (NCT05485766) | Okayama University | 2024-07-16 |
| EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy. (NCT06448572) | University Hospital, Lille | 2024-07-16 |
| Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria (NCT06687733) | NGGT (Suzhou) Biotechnology Co., Ltd. | 2024-07-16 |
| Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment (NCT06411210) | Yale University | 2024-07-16 |
| A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery (NCT06161441) | Regeneron Pharmaceuticals | 2024-07-16 |
| Agnostic Therapy in Rare Solid Tumors (NCT06638931) | Instituto do Cancer do Estado de São Paulo | 2024-07-16 |
| A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI) (NCT06465303) | ResoTher Pharma | 2024-07-16 |
| MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer (NCT06498752) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-07-16 |
| Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL (NCT05952024) | AstraZeneca | 2024-07-16 |
| Biomechanical Analysis of Distal Radius (Greenstick) Fracture Healing (NCT06510595) | Cairo University | 2024-07-16 |
| Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps (NCT06439381) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-07-16 |
| Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety (NCT06531278) | Jiang Long | 2024-07-16 |
| Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT06128070) | City of Hope Medical Center | 2024-07-16 |
| Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial (NCT07103980) | Shanghai Changzheng Hospital | 2024-07-16 |
| Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer (NCT06491472) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-07-15 |
| The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial. (NCT06633068) | Cairo University | 2024-07-15 |
| Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC (NCT06439550) | The First Affiliated Hospital of Zhengzhou University | 2024-07-15 |
| SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment (NCT06480136) | Shanghai Pulmonary Hospital, Shanghai, China | 2024-07-15 |
| BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer (NCT07108309) | Biocad | 2024-07-15 |
| Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer (NCT06483386) | Tianjin Medical University Cancer Institute and Hospital | 2024-07-15 |
| TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients (NCT06453902) | Shenzhen TargetRx Co., Ltd. | 2024-07-15 |
| Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults (NCT06036602) | Albert B. Sabin Vaccine Institute | 2024-07-15 |
| Comparison of the Efficacy of Diclofenac Sodium and Subcutaneous 5% Dextrose Injection in Low Back Pain. (NCT06829030) | Aksaray University Training and Research Hospital | 2024-07-15 |